[1]Buchapudi K, Xu X, Ataian Y, et al. Micromechanical measurement of AChBP binding for label-free drug discovery[J]. Analyst, 2011, 137(1):263-268.
[2]Brejc K, Smit AB, Sixma TK, et al. Crystal structure of ACh-binding protein reveals the ligand-binding domain of nicotinic receptors[J]. Nature, 2001, 411:269-276.
[3]Haga K, Kruse AC, Asada H, et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist[J].Nature, 2012, 482(7386):547-551.
[4]Buchapudi K, Xu X, Ataian Y, et al . Micromechanical measurement of AChBP binding for label-free drug discovery[J]. Analyst, 2011, 137(1):263-268.
[5]Kombo DC, Mazurov A, Tallapragad AK, et al. Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor(nAChR)and acetylcholine binding proteins(AChBPs):application to the design of related α7 selective ligands[J].Eur J Med Chem, 2011, 46(11):5625-5635.
[6]Turabekova MA, Rasulev BF, Dzhakhangirov FN, et al. Aconitum and Delphinium alkaloids of curare-like activity. QSAR analysis and molecular docking of alkaloids into AChBP[J]. Eur J Med Chem, 2010, 45(9):3885-3894.
[7]Hansen SB, Talley TT, Radic Z, et al. Structural and ligand recogni-tion characteristics of an acetylcholine-binding protein from Aplysia californica[J]. J Biol Chem, 2004, 279:24197-24202.
[8]Wang D, Zhang S, Li L, et al. Structural insights into the assembly and activation of IL-1 β with its receptors[J]. Nature Immunology, 2010, 11:905-911.
[9]Wang N, Shi X, Jiang L, et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4[J]. Cell Research, 2013, 23:986-993.
[10]Se' Bastien D, Chris U, Regina B, et al. AChBP-targeted a-conotoxin correlates distinct binding orientations with nAChR subtype selectivity[J]. The EMBO Journal, 2007, 26:3858-3867.
[11]Ulens C, Hogg RC, Celie PH, et al. Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine rece-ptor homolog AChBP[J]. Proc Natl Acad Sci USA, 2006, 103:3615-3620.
[12]Celie PH, Kasheverov IE, Mordvintsev DY, et al. Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant.[J]. Nat Struct Mol Biol, 2005, 12:582-588.
[13]Bourne Y, Talley T, Hansen SB, et al. Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors[J]. The EMBO Journal, 2005, 24:1512-1522.
[14]Celie PH, Klaassen RV, Van rossum-fikkert SE, et al. Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors[J]. J Biol Chem, 2005, 280:26457-26466.
[15]Eisele JL. Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities[J]. Nature, 1993, 366:479-483.
[16]Azam L, Mcintosh JM. Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors[J]. Acta Pharmacol Sin, 2009, 30:771-783.
[17]Billen B, Spurny R, Brams M, et al. Molecular actions of smoking cessation drugs at α4β2 nicotinic receptors defined in crystal structures of a homologous binding protein.[J].Proc Natl Acad Sci USA, 2012, 109(23):9173-9178.
[18]Geitmann M, Retra K, Dekloe GE, et al. Interaction kinetic and structural dynamic analysis of ligand binding to acetylcholine binding protein[J]. Biochemistry, 2010, 49(37):8143-8154. |